Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study
复制标题
DOI:
10.1016/j.bone.2012.06.002
复制
发表时间:
2012-09-01
期刊:
影响因子:
4.1
通讯作者:
Farina, Marco
中科院分区:
文献类型:
--
作者:
Gallieni, Maurizio;Caputo, Flavia;Farina, Marco
Background: Patients on dialysis may have abnormal serum levels of Ca, P and parathyroid hormone, with related bone diseases. This population has an increased risk of death, with cardiovascular calcification (CC) a contributing factor. Patients on peritoneal dialysis appear to be at increased risk of hyperlipidemia, a contributing factor to atherosclerotic plaque formation. Although several studies have described the presence and progression of CC in hemodialysis populations, there are fewer data in patients on peritoneal dialysis.Study design: The Renal Osteodystrophy and Calcifications: Key factors in Peritoneal Dialysis (ROCK-PD) study was a 36-month, prospective observational study conducted in Italy. The study examined the presence and progression of CC in two cardiac valves and five arterial sites. The potential associations of serum Ca and P with mortality and cardiovascular morbidity, demographic, clinical and blood chemistry variables was investigated.Results: CC was present in 77% of patients at baseline (N=369) and in 90% of patients by study end (N=145), progressing in 73% of patients. There were 42 deaths (11%). Analyses showed a marked correlation between baseline P levels and the presence of left ventricular hypertrophy. However, there were no consistent correlations between serum Ca or P with mortality or morbidity.Conclusions: CC was common in peritoneal dialysis patients and progressed in a majority of patients. (C) 2012 Elsevier Inc. All rights reserved.